Aspira Women's Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Aspira Women's Health generated cash of -$15,894,000, which is more than the previous year. Cash used in financing activities reached the amount of $5,216,000 last year. Net change in cash is therefore -$10,702,000.
Cash Flow
| 2014 | -16.80M | -258K | 10.52M |
|---|---|---|---|
| 2015 | -18.36M | -1.05M | 15.09M |
| 2016 | -13.96M | -1.26M | 1.82M |
| 2017 | -8.12M | -60K | 8.48M |
| 2018 | -9.36M | -113K | 13.30M |
| 2019 | -12.96M | -132K | 15.44M |
| 2020 | -14.73M | -490K | 20.15M |
| 2021 | -27.39M | -184K | 48.37M |
| 2022 | -32.18M | -232K | 7.42M |
| 2023 | -15.89M | -24K | 5.21M |
AWH Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 13.55M | 37.43M | 16.63M | 11.70M | 9.36M | 5.53M | 5.24M | 18.64M | 22.96M | 29.50M |
Operating activities | ||||||||||
Net income | -16.69M | -27.17M | -31.66M | -17.90M | -15.23M | -11.37M | -10.49M | -14.96M | -19.11M | -19.20M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 199K | 264K | 302K | 265K | 333K | 675K | 786K | 723K | 291K | 141K |
Stock-based compensation expense | 1.72M | 2.41M | 3.53M | 1.54M | 1.19M | 0 | 1.43M | 1.17M | 1.22M | 1.14M |
| Deferred income tax benefit | 1.72M | 2.41M | 3.53M | 1.54M | 1.19M | 0 | 1.43M | 1.17M | 1.22M | 1.14M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -214K | -218K | -162K | 59K | -138K | -81K | 70K | -188K | 80K | 206K |
Inventories | 89K | -142K | -144K | -5K | 67K | 10K | -9K | -6K | -87K | -162K |
Accounts payable | 380K | -2.22M | 2.24M | 1.59M | 971K | 380K | 50K | -851K | -129K | 1.5M |
Cash generated by operating activities | -15.89M | -32.18M | -27.39M | -14.73M | -12.96M | -9.36M | -8.12M | -13.96M | -18.36M | -16.80M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -24K | -232K | -184K | -490K | -133K | -113K | -60K | -1.26M | -1.05M | -258K |
Acquisitions Net | 0 | 0 | 0 | 0 | 1K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -24K | -232K | -184K | -490K | -132K | -113K | -60K | -1.26M | -1.05M | -258K |
Financing activities | ||||||||||
Common Stock Issued | 4.18M | 9M | 48.57M | 10.64M | 13.52M | 8.99M | 5.12M | 5K | 17.49M | 10.28M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -942K | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.29M | 0 |
Repayments of term debt | -148K | -261K | -198K | -191K | -189K | -214K | -217K | -148K | -13K | 0 |
Cash used in financing activities | 5.21M | 7.42M | 48.37M | 20.15M | 15.44M | 13.30M | 8.48M | 1.82M | 15.09M | 10.52M |
Net Change In Cash | -10.70M | -23.87M | 20.79M | 4.92M | 2.34M | 3.82M | 297K | -13.4M | -4.32M | -6.53M |
Cash at end of period | 2.85M | 13.55M | 37.43M | 16.63M | 11.70M | 9.36M | 5.53M | 5.24M | 18.64M | 22.96M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |